Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study published in EMBO Molecular Medicine.
Oct 4, 2023
0
30
Northwestern Medicine scientists have identified how one gene connects glioblastoma stem cell self-renewal to microglia immunosuppression in glioblastoma, according to a new study published in Nature Immunology.
Sep 27, 2023
0
36
Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) have successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time.
Sep 26, 2023
0
55
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern ...
Sep 22, 2023
0
59
The discovery of a previously unknown molecular target has inspired what may become a therapeutic breakthrough for people with glioblastoma, the most common and aggressive brain cancer.
Sep 11, 2023
0
92
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the brain from other parts of the body respond to immunotherapy while glioblastoma, an aggressive ...
Sep 1, 2023
0
57
Glioblastoma is a swift and aggressive brain cancer, with an average life expectancy of about one year after diagnosis. It's difficult to treat, in part because the cellular makeup of each tumor varies greatly from person ...
Aug 23, 2023
0
37
Glioblastoma, the most common and deadly form of brain cancer, grows rapidly to invade and destroy healthy brain tissue. The tumor sends out cancerous tendrils into the brain that make surgical tumor removal extremely difficult ...
Aug 11, 2023
0
54
More than 14,490 people in the U.S. will be diagnosed with glioblastoma in 2023, according to the National Brain Tumor Society, and 10,000 people in the U.S. will die of the disease. The five-year survival rate is 6.9%, and ...
Jul 22, 2023
0
2
"Don't eat me," is how one might translate the signal that the cancer cells in a glioblastoma send to the macrophages (white blood cells specialized in removing dead and dying cellular matter) in the brain. Immunotherapy ...
Jul 19, 2023
0
16
